These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34623133)

  • 1. Characterization of Metabolites in a Zebrafish Model of Alzheimer's Disease Supplemented with Mussel-Derived Plasmalogens by Ultraperformance Liquid Chromatography Q-Exactive Orbitrap Mass Spectrometry-Based Unbiased Metabolomics.
    Zhang M; Song G; Wang S; Ge L; Liu F; Zhang M; Xie H; Feng J; Shen Q
    J Agric Food Chem; 2021 Oct; 69(41):12187-12196. PubMed ID: 34623133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic Analysis of Postmortem Prefrontal Cortex Phospholipids Reveals Changes in Choline Plasmalogen Containing Docosahexaenoic Acid and Stearic Acid Between Cases With and Without Alzheimer's Disease.
    Otoki Y; Kato S; Nakagawa K; Harvey DJ; Jin LW; Dugger BN; Taha AY
    Neuromolecular Med; 2021 Mar; 23(1):161-175. PubMed ID: 33475971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
    Gu Y; Zang P; Li J; Yan Y; Wang J
    Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
    Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomics integrated with metabolomics reveals the ameliorating effect of mussel-derived plasmalogens on high-fat diet-induced hyperlipidemia in zebrafish.
    Feng J; Chen X; Wang S; Zhang J; Wang Q; Guo S; Shen Q
    Food Funct; 2023 Apr; 14(8):3641-3658. PubMed ID: 36961308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of plasmalogens on AlCl
    Zhang J; Guo S; Tao R; Wang F; Xie Y; Wang H; Ding L; Shen Y; Zhou X; Feng J; Shen Q
    Neurosci Lett; 2024 Jan; 818():137560. PubMed ID: 37979715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
    Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel strategy for rapidly and accurately screening biomarkers based on ultraperformance liquid chromatography-mass spectrometry metabolomics data.
    Li C; Zhang J; Wu R; Liu Y; Hu X; Yan Y; Ling X
    Anal Chim Acta; 2019 Jul; 1063():47-56. PubMed ID: 30967185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmalogens improve swimming performance by modulating the expression of genes involved in amino acid and lipid metabolism, oxidative stress, and ferroptosis in an Alzheimer's disease zebrafish model.
    Feng J; Song G; Wu Y; Chen X; Pang J; Xu Y; Shen Q; Guo S; Zhang M
    Food Funct; 2021 Nov; 12(23):12087-12097. PubMed ID: 34783821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Identification of Tanshinone IIA Metabolites in an Amyloid-β
    Liang S; Wang Z; Yuan J; Zhang J; Dai X; Qin F; Zhang J; Sun Y
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31315255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
    Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
    Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer's disease cell model induced by Aβ
    Zhang M; Liu Y; Liu M; Liu B; Li N; Dong X; Hong Z; Chai Y
    Metabolomics; 2019 Jan; 15(2):13. PubMed ID: 30830431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in S. chinensis in treating Alzheimer's disease using UPLC-Q-TOF-MS.
    Wei M; Liu Z; Liu Y; Li S; Hu M; Yue K; Liu T; He Y; Pi Z; Liu Z; Song F
    Food Funct; 2019 Sep; 10(9):5656-5668. PubMed ID: 31433414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Metabolites and Mechanism Analysis of Genistin against Hyperlipidemia via the UHPLC-Q-Exactive Orbitrap Mass Spectrometer and Metabolomics.
    Li Z; Dong W; Li Y; Liu X; Wang H; Dai L; Zhang J; Wang S
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and urinary metabolomics studies on the mechanism of Schisandra polysaccharide in the treatment of Alzheimer's disease.
    Liu Y; Liu Z; Wei M; Hu M; Yue K; Bi R; Zhai S; Pi Z; Song F; Liu Z
    Food Funct; 2019 Jan; 10(1):432-447. PubMed ID: 30623955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic profiling of the effects of ginsenoside Re in an Alzheimer's disease mouse model.
    Li J; Liu Y; Li W; Wang Z; Guo P; Li L; Li N
    Behav Brain Res; 2018 Jan; 337():160-172. PubMed ID: 28927718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
    Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
    J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing serum metabolic alterations of Alzheimer's disease and intervention of Shengmai-San by ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry.
    Lu S; Han Y; Chu H; Kong L; Zhang A; Yan G; Sun H; Wang P; Wang X
    Food Funct; 2017 Apr; 8(4):1660-1671. PubMed ID: 28379235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease.
    Greenberg N; Grassano A; Thambisetty M; Lovestone S; Legido-Quigley C
    Electrophoresis; 2009 Apr; 30(7):1235-9. PubMed ID: 19288586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.